Literature DB >> 26905813

Gender-specific associations of genetic variants with metabolic syndrome components in the Tunisian population.

Sahar Elouej1,2, Insaf Rejeb1,2, Redha Attaoua3, Majdi Nagara1,2, Om Kalthoum Sallem1,4, Ines Kamoun5, Mariem Chargui1, Henda Jamoussi1,4, Zinet Turki5, Abdelmajid Abid1,4, Claude Ben Slama5, Sonia Bahri2,6, Habiba Ben Romdhane7, Sonia Abdelhak1,2, Rym Kefi1,2, Florin Grigorescu3.   

Abstract

AIM OF THE STUDY: Recent genome-wide association studies (GWASs) have identified many genetic variants associated with metabolic syndrome (MetS). However, their contribution to MetS in ethnic groups in Tunisia is largely unexplored. In this study, we aim to examine the associations of related loci with a risk of metabolic syndrome in a sample of Tunisians.
MATERIALS AND METHODS: Overall seven polymorphisms rs7265718, rs10401969, rs762861, rs12310367, rs1562398, rs2059807, rs4420638 located at C20orf152, CILP2, LRPAP1, ZNF664, KLF14, INSR, APOE, respectively, were analyzed in 356 samples from the Tunisian population. Anthropometric and biochemical parameters were assessed. Metabolic syndrome was defined according to the International Diabetes Federation (IDF).
RESULTS: We find that LRPAP1-rs762861 C allele increases susceptibility to MetS (OR = 1.39, 95% CI = 0.99-1.95, p = 0.041). Separate analysis in men and women revealed the association of rs762861 among females (OR = 1.6, 95% CI = 1.057-2.41, p = 0.021), but not among males (OR = 0.953, 95% CI = 0.51-1.78, p = 0.882). ZNF664-rs12310367 was also found to be associated with body mass index (BMI) in women (p = 0.01) and not in men (p = 0.18). KLF14-rs1562398 was significantly correlated with impaired fasting glucose (p = 0.004) only in men.
CONCLUSIONS: Our results reveal new candidate genes for MetS in the Tunisian population and suggest that the genetic basis of this syndrome is gender dependent. Further studies are necessary to understand why these associations differ between males and females.

Entities:  

Keywords:  Gender; North Africa; Tunisia; metabolic syndrome; polymorphisms

Mesh:

Year:  2016        PMID: 26905813     DOI: 10.3109/07435800.2016.1141945

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  5 in total

1.  Genetic Determinants of Dyslipidemia in African-Based Populations: A Systematic Review.

Authors:  Jean Jacques Noubiap; Edith Pascale M Mato; Magellan Guewo-Fokeng; Arnaud D Kaze; Houssam Boulenouar; Ambroise Wonkam
Journal:  OMICS       Date:  2018-12

2.  PCOS-GWAS Susceptibility Variants in THADA, INSR, TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance in Women With PCOS.

Authors:  Ye Tian; Jingyu Li; Shizhen Su; Yongzhi Cao; Zhao Wang; Shigang Zhao; Han Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-30       Impact factor: 5.555

3.  Association of rs662799 variant and APOA5 gene haplotypes with metabolic syndrome and its components: a meta-analysis in North Africa.

Authors:  Meriem Hechmi; Hamza Dallali; Meriem Gharbi; Haifa Jmel; Meriem Fassatoui; Yossra Ben Halima; Sonia Bahri; Afaf Bahlous; Abdelmajid Abid; Henda Jamoussi; Abdelhamid Barakat; Rym Kefi
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

4.  Lack of association between genetic variants in the 19q13.32 region and CHD risk in the Algerian population: a population-based nested case-control study.

Authors:  Houssam Boulenouar; Sarah Aicha Lardjam Hetraf; Hadjira Ouhaibi Djellouli; Djabaria Naima Meroufel; Faouzia Zemani Fodil; Imane Hammani-Medjaoui; Nadhira Saidi Mehtar; Leila Houti; Sounnia Mediene Benchekor
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

5.  APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study.

Authors:  Ying-Hui Lee; Ya-Sian Chang; Chih-Chang Hsieh; Rong-Tsorng Wang; Jan-Gowth Chang; Chung-Jen Chen; Shun-Jen Chang
Journal:  Genet Mol Biol       Date:  2022-02-21       Impact factor: 1.771

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.